Effect of sinomenine on human cytochrome P450 activity

Clinica Chimica Acta

Volumn 379, Issue 1-2, 2007, Pages 113-118

  Yao, Yong Mei ^b   Cao, Wei ^c   Cao, Ya Jie ^c   Cheng, Ze Neng ^c   Ou Yang, Dong Sheng ^a   Liu, Zhao Qian ^a   Zhou, Hong Hao ^a  

^a Central South University   (China)

^b Hunan Food and Drug Administration   (China)

^c CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Cytochrome P450; Induce; Inhibit; Sinomenine

Indexed keywords

CAFFEINE; CHLORZOXAZONE; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; MEPHENYTOIN; MIDAZOLAM; SINOMENINE; TOBUTAMIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DRUG EFFECT; DRUG ELIMINATION; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; IN VIVO STUDY; INCUBATION TIME; MALE; MICROSOME; NORMAL HUMAN; PRIORITY JOURNAL;

ANTICONVULSANTS; CYTOCHROME P-450 ENZYME SYSTEM; HUMANS; MEPHENYTOIN; MICROSOMES, LIVER; MORPHINANS;

RATTUS;

EID: 33847642051     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.12.022     Document Type: Article

References (29)

1. Liu Q., Zhou L.-l., and Li R. General development of sinomenine in chemistry, pharmacology and clinics. Chin Tradit Herb Drugs 28 4 (1997) 247
2. Yang P., Yang L.-y., and Luo Z.-g. Effects of sinomenine on IL-2 in rat renal allograft transplantation model. Chin J Mod Med 13 (2003) 21
3. Dai Y.-b., Huang X., Luo Z.-g., et al. Immunosuppressive effect of sinomenine on ICAM-1 expression in rat renal allograft rejection. Mod J Integr Trad Chin West Med 12 (2003) 1358
4. Yang P., Yang L.-y., and Luo Z.-g. Effects of sinomenine on T lymphocyte subsets in rat renal allograft transplantation model. J Clin Urol 18 (2003) 620-622
5. Wang C.-y., Mo Z.-x., and Liang R.-n. Effects of sinomenine on withdrawal syndrome in morphine-dependent mice. Pharm J Chin PLA 18 (2002) 134-136
6. Wang C.-y., Mo Z.-x., Zhu Q.-s., and Wen L. Effect of sinomenine on withdrawal symptom and neurotransmitter of morphine-dependent rats. Zhong Yao Cai 25 (2002) 337-339
7. Wang C.-y., Mo Z.-x., and Tu H.-h. Effect of sinomenine on morphine dependence in isolated guinea pig ileum. Di Yi Jun Yi Da Xue Xue Bao 23 (2003) 329-331
8. Hu X.-d., and Li F.-y. Effects of sinomenine on morphine withdrawal syndromes in mice, rats and guinea pig ileum. Chin J Drug Depend 12 (2003) 28-31
9. Wang C.-y., Mo Z.-x., and Shao H.-x. Effects of sinomenine on the psychic dependence on morphine and the brain cyclic AMP level in mice. Chin Pharmacol Bull 19 (2003) 575-577
10. Yan X.H., Li H.D., Peng W.X., Liu F.Q., Shao Y., and He Y.Q. Determination of sinomenine HCL in serum and urine by HPLC and its pharmacokinetics in normal volunteers. Yao Xue Xue Bao 32 (1997) 620-624
11. Hong-Hao Zhou et al. Pharmacogenetics 2003. (November)
12. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with Folin phenol reagent. J Biol Chem 193 (1951) 265-275
13. Ou-Yang D.-S., Huang S.-L., Xie H.-G., Wang C.-Y., and Zhou H.-H. Use of caffeine as a probe for rapid determination of cytochrome P450 CYP1A2 activity in humans. Acta Pharmacol Sin 19 (1998) 44-46
14. Ko J.W., Sukhova N., Thacker D., Chen P., and Flockhart D.A. Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms. Drug Metab Dispos 25 (1997) 853-862
15. Thumml K.E., Shen D.D., Prodoll T.D., et al. Use of midazolam as a human cytochrome P450 3A probe II.Characterization of inter- and intra-indvidual hepatic CYP3A variability after liver transplantation. J Pharmacol Exp Ther 271 (1994) 557-566
16. Peter R.R., Bocker P.H., Beaune M., Iwaski F.P., Guengerich C., and Xang S. Hydroxylation of chlorzoxazone as a specific probe of cytochrome P450 IIE1. Chem Res Toxicol 3 (1990) 566-573
17. Shin J.-G., Soukhova N., and Flockhart D.A. Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in vitro: preferential inhibition of CYP2D6. Drug Metab Dispos 27 (1999) 1078-1084
18. Shu Y., Wang L.-S., Xiao W.-M., Wang W., Huang S.-l., and Zhou H.-H. Probing CYP2C19 and CYP3A4 activities in Chinese liver microsomes by quantification of 5-hydroxyomeprazole and omeprazole sulphone. Acta Pharmacol Sin 21 (2000) 753-758
19. Zhu B., Ou-Yang D.-S., Chen X.-P., et al. Assessment of cytochrome P450 activity by a five-drug cocktail approach. Clin Pharmacol Ther (2001) 455-461 (November)
20. Cai M.-H., Wang S.-J., and Hang Y.-N. Determination of the Concentration of Midazolam in Plasma by RP-HPLC-UV Detection. Chin Pharm 13 (2002) 157-158
21. Zhang D., Zeng J.-Z., Jiang Y., Zhao J.-D., and Li T. Determination and pharmacokinetics study of gliclazide in human plasma by HPLC. Chin J Pharm Anal 16 (1996) 157-160
22. He H.-B., Liu D.-L., Yue Q.-Y., and Wang Y.-L. RP-HPLC for determination of chlorzoxazone in human plasma. Acta Univ Med Shanghai 17 (1990) 309
23. Xie W.-B., Li H.-D., Zhang B.-K., Peng W.-X., Wang G.-P., and Hu W.-J. Compare study on dissolution and bioavailability of metoprolol tartrate tablets by two plants manufactured. J Hum Med Coll 3 (2001) 1-5
24. Huang S.-L., Xie H.-G., and Wang W. Determination of S/R ratio of mephenytoin in human urine by chiral HPLC and ultraviolet detection and its comparison with gas chromatography. Acta Pharm 19 (1998) 548-550
25. Zhu B., Ou-Yang D.-S., and Cheng Z.-N. Single plasma sampling to predict oral clearance of CYP3A4 probe midazolam. Acta Pharmacol Sin 22 (2001) 634-638
26. Chen X.-P., Han X.-M., and Jiang C.-H. Phenotype distribution and gender-related differences of CYP2E1 activity in a Chinese population. Xenobiotica 32 (2002) 1053-1062
27. Wu Y.-P., and Wei L. Simultaneous determination of prapafenone and metoprolol in plasma by HPLC. Chin New Drugs J 9 (2000) 99
28. Xie H.-G., and Huang S.-L. High-performance liquid chromatographic determination of urinary 4′-hydroxymephenytoin, a metabolic marker for the hepatic enzyme CYP2C19, in humans. Chromatogr B Biomed Appl 668 (1995) 125-131
29. Rengelshausen J., Banfield M., Riedel K.-D., et al. Opposite effects of short-term and long-term St John's wort intake on voriconazole pharmacokinetics. Clin Pharmacol Ther 78 (2005) 25-33